208 related articles for article (PubMed ID: 15946307)
1. Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure.
Knudsen LM; Nielsen B; Gimsing P; Geisler C
Eur J Haematol; 2005 Jul; 75(1):27-33. PubMed ID: 15946307
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
Ballester OF; Tummala R; Janssen WE; Fields KK; Hiemenz JW; Goldstein SC; Perkins JB; Sullivan DM; Rosen R; Sackstein R; Zorsky P; Saez R; Elfenbein GJ
Bone Marrow Transplant; 1997 Oct; 20(8):653-6. PubMed ID: 9383228
[TBL] [Abstract][Full Text] [Related]
3. Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study.
Tricot G; Alberts DS; Johnson C; Roe DJ; Dorr RT; Bracy D; Vesole DH; Jagannath S; Meyers R; Barlogie B
Clin Cancer Res; 1996 Jun; 2(6):947-52. PubMed ID: 9816255
[TBL] [Abstract][Full Text] [Related]
4. The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.
Bird JM; Fuge R; Sirohi B; Apperley JF; Hunter A; Snowden J; Mahendra P; Milligan D; Byrne J; Littlewood T; Fegan C; McQuaker G; Pagliuca A; Johnson P; Rahemtulla A; Morris C; Marks DI;
Br J Haematol; 2006 Aug; 134(4):385-90. PubMed ID: 16822294
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
6. The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure.
Raab MS; Breitkreutz I; Hundemer M; Benner A; Klaus J; Hegenbart U; Moehler T; Ho AD; Zeier M; Goldschmidt H
Haematologica; 2006 Nov; 91(11):1555-8. PubMed ID: 17082013
[TBL] [Abstract][Full Text] [Related]
7. Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.
Lee CK; Zangari M; Barlogie B; Fassas A; van Rhee F; Thertulien R; Talamo G; Muwalla F; Anaissie E; Hollmig K; Tricot G
Bone Marrow Transplant; 2004 Apr; 33(8):823-8. PubMed ID: 14767499
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
O'Shea D; Giles C; Terpos E; Perz J; Politou M; Sana V; Naresh K; Lampert I; Samson D; Narat S; Kanfer E; Olavarria E; Apperley JF; Rahemtulla A
Bone Marrow Transplant; 2006 Apr; 37(8):731-7. PubMed ID: 16501593
[TBL] [Abstract][Full Text] [Related]
9. Recovery of renal function after autologous stem cell transplantation in myeloma patients with end-stage renal failure.
Tauro S; Clark FJ; Duncan N; Lipkin G; Richards N; Mahendra P
Bone Marrow Transplant; 2002 Oct; 30(7):471-3. PubMed ID: 12368962
[TBL] [Abstract][Full Text] [Related]
10. Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma.
Qazilbash MH; Saliba R; De Lima M; Hosing C; Couriel D; Aleman A; Roden L; Champlin R; Giralt SA
Cancer; 2006 Mar; 106(5):1084-9. PubMed ID: 16456814
[TBL] [Abstract][Full Text] [Related]
11. Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma.
Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Leung N; Gastineau DA
Bone Marrow Transplant; 2007 May; 39(10):605-11. PubMed ID: 17369867
[TBL] [Abstract][Full Text] [Related]
12. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
[TBL] [Abstract][Full Text] [Related]
13. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
[TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA
Am J Hematol; 2008 Aug; 83(8):614-7. PubMed ID: 18429054
[TBL] [Abstract][Full Text] [Related]
15. Melphalan 200 mg/m2 with blood stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival.
Carlson K
Bone Marrow Transplant; 2005 May; 35(10):985-90. PubMed ID: 15806125
[TBL] [Abstract][Full Text] [Related]
16. Peri-operative renal function and outcome after orthotopic heart transplantation.
Odim J; Wheat J; Laks H; Kobashigawa J; Gjertson D; Osugi A; Mukherjee K; Saleh S
J Heart Lung Transplant; 2006 Feb; 25(2):162-6. PubMed ID: 16446215
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.
Vogl DT; Liu SV; Chong EA; Luger SM; Porter DL; Schuster SJ; Tsai DE; Perl A; Loren AW; Goldstein SC; Nasta SD; Andreadis C; Mangan PA; Hummel K; Siegel DL; Glatstein E; Stadtmauer EA
Am J Hematol; 2007 Dec; 82(12):1071-5. PubMed ID: 17696204
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome after coronary angioplasty in renal transplant and hemodialysis patients.
Borentain M; Le Feuvre C; Helft G; Beygui F; Batisse JP; Drobinski G; Metzger JP
J Interv Cardiol; 2005 Oct; 18(5):331-7. PubMed ID: 16202107
[TBL] [Abstract][Full Text] [Related]
19. Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
Christoforidou AV; Saliba RM; Williams P; Qazilbash M; Roden L; Aleman A; Weber D; Mendoza F; Podoloff D; Wendt R; Breitz H; Alexanian R; Champlin R; Giralt S
Biol Blood Marrow Transplant; 2007 May; 13(5):543-9. PubMed ID: 17448913
[TBL] [Abstract][Full Text] [Related]
20. Impact of renal failure on liver transplantation survival.
Afonso RC; Hidalgo R; Zurstrassen MP; Fonseca LE; Pandullo FL; Rezende MB; Meira-Filho SP; Ferraz-Neto BH
Transplant Proc; 2008 Apr; 40(3):808-10. PubMed ID: 18455024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]